开发针对TET蛋白的新型表观遗传抗癌疗法
Hyejin Kim1, Inkyung Jung1, Chan Hyeong Lee2
1Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
International journal of molecular sciences
|November 25, 2023
概括
该研究确定了线粒作为十一转位 (TET) 蛋白的新型激活剂. 这种化合物增强了TET活性,导致癌细胞死亡,为表观遗传癌症治疗提供了新的途径.
科学领域:
- 生物化学 生物化学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 表观遗传失调,包括改变的DNA甲基化和基甲基化,对于癌症的发展至关重要.
- 十-十一转位 (TET) 蛋白调节DNA甲基化动态,通过氧化5-甲基细胞因子 (5mC) 到5-基甲基细胞因子 (5hmC).
- TET蛋白功能障碍有助于癌症,而它们的激活显示出抗癌潜力,使它们成为治疗点.
研究的目的:
- 开发一种基于细胞的查系统,用于识别新型TET激活剂.
- 评估已识别的TET激活剂的抗癌潜力.
- 调查已识别的化合物的作用机制.
主要方法:
- 利用了来自国家癌症研究所的4533种化合物的库进行查.
- 雇佣了免疫组织化学和点滴测试进行验证.
- 对野生类型和TET缺乏细胞,包括小鼠胚胎纤维细胞,巨细胞和白血病细胞系的测试化合物效应.
主要成果:
- 确定了米托克桑作为一种强大的TET激动剂.
- 证明米托克桑能以TET-依赖的方式显著增加5hmC水平.
- 显示,米托克桑能特别通过TET活性诱导白血病细胞的细胞死亡.
结论:
- 米托克桑恢复TET活性,通过一种新的表观遗传机制导致瘤细胞死亡.
- 这一发现支持针对癌症的向表观遗传疗法的开发.
- 米托克桑特龙通过重新激活TET蛋白来代表表观遗传癌症治疗的有希望的候选人.
更多相关视频
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
8.3K
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.6K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
